| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.6B | $54.2B | $52.8B | $49.0B | $29.9B | $4.0B | $11.3B | $10.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $2.6B | $3.0B | $1.6B | $-1.1B | $-2.5B | $0.7B | $0.6B |
| Net Income | $0.1B | $0.8B | $0.8B | $0.1B | $-2.0B | $-2.2B | $0.4B | $0.3B |
| EPS (Basic) | $0.17 | $1.29 | $1.26 | $0.20 | $-3.09 | $-18.36 | $0.95 | $0.71 |
| EPS (Diluted) | $0.17 | $1.24 | $1.21 | $0.19 | $-3.09 | $-18.36 | $0.95 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $61.8B | $61.8B | $63.1B | $64.7B | $66.5B | $62.0B | $60.0B | $60.6B |
| Current Assets | $12.2B | $13.2B | $13.6B | $15.3B | $17.3B | $11.1B | $8.2B | $8.6B |
| Cash & Equivalents | $1.0B | $0.8B | $0.6B | $0.4B | $0.3B | $0.2B | $0.3B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $24.5B | $24.3B | $22.1B | $21.5B | $19.0B | $16.6B | $18.3B | $18.1B |
| Stockholders' Equity | $-3.7B | $-4.0B | $-5.2B | $-5.8B | $-7.3B | $-6.9B | $-0.1B | $-0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $4.0B | $3.8B | $2.2B | $0.7B | $-6.5B | $3.8B | $3.5B |
| Investing Cash Flow | $-1.9B | $-1.0B | $-0.5B | $0.6B | $-6.0B | $-4.3B | $-2.2B | $-2.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-2.8B | $-3.2B | $-2.6B | $5.3B | $11.0B | $-1.6B | $-1.7B |